Adjacent (not core)
Combining brigatinib with mTOR inhibition to effectively treat NF2-SWN-associated and sporadic NF2-deficient meningiomas
GSE307286Chang et al., 2026
Overview
- Modality
- Bulk RNA-seq
- Sample count
- 12
- Patient count
- Not applicable (cell line)
- Institution
- Abigail Wexner Institute at Nationwide Children's Hospital
- Corresponding author
- Long-Sheng Chang, Janet L Oblinger
- Platform
- Illumina NovaSeq 6000 (GPL24676)
- Access type
- open
- Tissue preservation
- not_applicable
- WHO edition
- Not applicable (cell line)
Cohort detail
- Grade breakdown
- Not reported
- Sex distribution
- Not applicable
- Age distribution
- Not applicable
- Anatomic location
- Not applicable (cell line)
- Brain invasion
- Not reported
- Normal/control tissue
- None
Priority attributes
Peer-reviewed
Publications
- Chang LS, et al. Combining Brigatinib with mTOR Inhibition to Effectively Treat NF2-SWN-Associated and Sporadic NF2-Deficient Meningiomas. Cancer research communications, 2026. PMID 41417846 · DOI